[go: up one dir, main page]

WO2013010483A1 - Construction method of escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism - Google Patents

Construction method of escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism Download PDF

Info

Publication number
WO2013010483A1
WO2013010483A1 PCT/CN2012/078817 CN2012078817W WO2013010483A1 WO 2013010483 A1 WO2013010483 A1 WO 2013010483A1 CN 2012078817 W CN2012078817 W CN 2012078817W WO 2013010483 A1 WO2013010483 A1 WO 2013010483A1
Authority
WO
WIPO (PCT)
Prior art keywords
escherichia coli
gene
fermentation
succinic acid
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2012/078817
Other languages
French (fr)
Chinese (zh)
Inventor
姜岷
刘嵘明
梁丽亚
马江锋
陈可泉
韦萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Publication of WO2013010483A1 publication Critical patent/WO2013010483A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • C12P7/46Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01031Phosphoenolpyruvate carboxylase (4.1.1.31)

Definitions

  • the invention belongs to the field of bioengineering technology, and relates to a method for constructing a genetically engineered bacterium of succinic acid using xylose metabolism.
  • Succinic acid also known as succinic acid
  • succinic acid is widely used in the pharmaceutical, pesticide, dye, fragrance, paint, food and plastic industries.
  • As a C4 platform compound it can be used to synthesize 1,4-butanediol, tetrahydrofuran, Organic chemicals such as ⁇ -butyrolactone and polybutylene succinate (PBS) biodegradable materials are considered by the US Department of Energy to be one of the 12 most valuable biorefining products in the future.
  • PBS polybutylene succinate
  • the production method of succinic acid mainly includes chemical synthesis method and microbial fermentation method, and uses microbial fermentation method to convert renewable resources (glucose, xylose, etc.), due to wide source and low price of raw materials, low pollution, environmental friendliness, and in the fermentation process. It can absorb fixed C0 2 , which can effectively alleviate the greenhouse effect and open up a new way of utilizing greenhouse gas carbon dioxide. This year has become a research hotspot.
  • the production strain of succinic acid is mainly concentrated in Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes ⁇ Mannheimia succiniciproducens ⁇ recombinant Corynebacterium glutamicum and recombinant E.coIi.
  • succinic acid by wild strains has obtained a higher product concentration, the culture medium cost is higher, and by-products such as formic acid and acetic acid accumulate more, hindering the industrialization process.
  • E.coli has been widely used in recent years to obtain excellent strains of succinic acid production due to its clear genetic background, easy operation, easy regulation, simple medium requirements and rapid growth.
  • Corn cob is a common waste in agricultural production. Because its composition contains a lot of cellulose, its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high The concentration of xylose, therefore E. coli NZN111 can not be fermented using corn cob hydrolysate to produce succinic acid. Jiang Yan et al.
  • Straw straw is an important class of renewable biomass resources. At present, most of them are discarded except for the use in the paper industry, which wastes resources and pollutes the environment. Its main components are cellulose, hemicellulose and lignin, so its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high concentration of xylose, so it can not E. coli strains using xylose could not be fermented by straw straw hydrolysate to produce succinic acid.
  • Tao Wenqi et al. treated straw straw with dilute sulfuric acid at 121 °C for 1 h, and treated 20 g/L NaOH at 121 °C for 1 h. The total mass concentration of both glucose and xylose is about 50 g/L.
  • Bagasse is the main component left after sugar cane sugar production. Therefore, its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high concentration of xylose. Therefore, the E. coli strain which cannot utilize xylose can not be fermented to produce succinic acid by using straw straw hydrolysate, and about 50% of cellulose can be obtained by pulverization and alkali/oxidation pretreatment to obtain a total sugar mass of 50 g/L, wherein wood Sugar accounts for more than 80%.
  • oxaloacetate is produced by phosphoenolpyruvate carboxylase, in the process without ATP formation, but in In rato fc, phosphoenolpyruvate produces oxaloacetate by phosphoenolpyruvate carboxylation kinase, in which ATP is produced, and Millard et al. overexpress E. coli ppc and E. coli.
  • the technical aim of the present invention is to provide a method for constructing an Escherichia coli strain based on ATP biosynthesis system, and the method for constructing the strain is simple and convenient, and the fermentation method of the constructed strain is simple and feasible, easy to industrialize, and capable of producing acid.
  • the purpose is to greatly reduce production costs and improve economic efficiency.
  • the present invention adopts the following technical solutions.
  • a method for constructing a succinic acid Escherichia coli genetically engineered bacterium by utilizing xylose metabolism comprising the steps of:
  • the E.coli NZN111 strain lacking lactate dehydrogenase gene ldhA and pyruvate formate lyase gene pflB activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out, which resulted in the lack of WM. Competent strains of pflB and PPC;
  • a pair of primers with a restriction enzyme site at the 5' end were synthesized, and the amplified gene was purified by using BadU s ⁇ rifc genomic DNA as a template.
  • the expression plasmid pTrc99a was doubled with the enzyme cleavage site designed by the primer. Digestion, ligation to obtain recombinant plasmid pTrc99a- ct;
  • the plasmid ⁇ 99 ⁇ -;7 ⁇ was introduced to eliminate the apramycin resistance, and the competent state of the NZN111 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • the positive transformant obtained was Escherichia coli BA204. ;
  • Escherichia coli BA204 was used to overexpress phosphoenolpyruvate carboxylase to restore its ability to metabolize xylose under anaerobic conditions.
  • the constructed map of the recombinant plasmid ⁇ - ⁇ is shown in Fig. 3.
  • the E. coli NZN111 strain lacking the lactate dehydrogenase gene (intestine') and the pyruvate formate lyase gene (pflB) activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. Simultaneous lack of competent strains of WM, pflB and PPC;
  • a pair of primers carrying the same restriction site at the 5' end were synthesized, and the amplified ppk gene was purified by using ⁇ 7/ ⁇ ' genomic DNA as a template, and the recombinant plasmid pTr C 99a- o was constructed.
  • the enzyme is digested with the enzyme cleavage site designed by the primer, and the recombinant plasmid pTrc99a-Ji h -; jd:;
  • the competent transformant obtained by introducing the plasmid pT rC 99a- ⁇ l-pd to eliminate apramycin resistance, knocked out the NZN1 11 strain of the decanoic pyruvate carboxylase (PPC) gene, and obtained the positive transformant That is Escherichia coli BA205;
  • Escherichia coli BA205 was used to co-express phosphoenolpyruvate carboxylase and malic enzyme to restore its ability to metabolize xylose under anaerobic conditions.
  • the construction map of the recombinant plasmid ⁇ 3 ⁇ 49 - -/ ⁇ is shown in Fig. 4.
  • WM lactate dehydrogenase gene
  • PPC phosphoenolpyruvate carboxylase
  • a pair of primers carrying the same restriction site at the 5' end were synthesized, and the amplified ppk gene was purified by using ⁇ '3 ⁇ 4 « ⁇ 7 ⁇ genomic DNA as a template, and the constructed recombinant plasmid pTrc99a-TMft was used.
  • the enzyme was digested with the enzyme cleavage site designed by the primer, and the recombinant plasmid pTrc99a-wtt i-;?d was obtained;
  • the plasmid pT rc 99 a -TM3 ⁇ 4-;7 C t was introduced before the apramycin resistance was eliminated, and the competent state of the NZN1 11 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • the positive transformant is Escherichia coli BA206;
  • Escherichia coli BA206 was used to co-express phosphoenolpyruvate carboxylase and malate dehydrogenase to restore its ability to metabolize xylose under anaerobic conditions.
  • the construction map of the recombinant plasmid ⁇ 99 dh-pck is shown in Fig. 5.
  • the E.coli NZN111 strain lacking lactate dehydrogenase gene IdhA and pyruvate formate lyase gene ipflB activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out, which resulted in the lack of WM and pflB. Competent strains of PPC;
  • a pair of primers carrying the same restriction site at the 5' end were synthesized and purified by using ad3 ⁇ 4 «TMM genomic DNA as a template; after the * gene, the constructed recombinant plasmid pT rc 99 a -;? yc The recombinant plasmid pTrc99a-/ ⁇ c-pcJt was obtained by single enzyme digestion and ligation with the enzyme cleavage site designed by the primer;
  • the plasmid ⁇ ⁇ - ⁇ - ⁇ was introduced before the introduction of the NZN1 11 strain which amplifies the resistance to apramycin, and the phosphoenolpyruvate carboxylase PPC gene was knocked out.
  • the positive transformant obtained was Escherichia coli BA207;
  • Escherichia coli BA207 was used to co-express phosphoenolpyruvate carboxylase and pyruvate carboxylase to restore its ability to metabolize xylose under anaerobic conditions.
  • the constructed map of the recombinant plasmid ⁇ ;99 - ⁇ - ⁇ is shown in Fig. 6.
  • the present invention modifies the ATP biosynthesis pathway of Escherichia coli by molecular biological means, increases the supply of ATP, supplements the energy supply in the xylose transport and metabolism process, enables the recombinant Escherichia coli to continue to utilize xylose growth and efficiently synthesize it.
  • the method of diacid has not been disclosed, and this application will greatly advance the progress and development of the succinic acid industry.
  • DRAWINGS Figure 1 Electrophoretic identification of a linear DNA fragment.
  • FIG. 1 Construction map of the recombinant plasmid pTrc99a-p.
  • Figure 4 Construction map of recombinant plasmid pTrc99a--/ ⁇ .
  • Figure 7 Agarose gel electrophoresis identification of the PCR product pck.
  • Figure 10 is a single double-digestion identification map of the recombinant plasmid pTrc99a-mi- P ( ⁇ .
  • Figure 11 is a single-double digestion map of the recombinant plasmid pTrc99a-; ⁇ c-pd.
  • the source of the apramycin resistance gene of the present invention is: pIJ773, obtained from Professor Shao Weilan of Nanjing Normal University.
  • the source of the plasmid capable of inducing expression of the lambda recombinase of the present invention is: pKD46, available from Introvegen.
  • the source of the plasmid capable of inducing the production of FLP recombinase according to the present invention is: pCP20, purchased from Introvegen.
  • the source of the Bacillus subtilis genome of the present invention is: purchased from the China Center for Type Culture Collection.
  • the source of pTrc99a for the expression plasmid of the present invention is: purchased from Introvegen.
  • the starting strain of the present invention ⁇ .
  • the source of the competent strain of ⁇ 111 has two places:
  • the design and synthesis of the primers of the present invention self-designed and outsourced synthesis by Kingsray Biotech.
  • This example illustrates the construction of an expression plasmid overexpressing phosphoenolpyruvate carboxylase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions to obtain the strain Escherichia coli BA204.
  • the .co/ NZNl ll strain lacking lactate dehydrogenase gene (WM) and pyruvate formate lyase gene pflB ⁇ ) was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • a competent strain lacking both WM, pflB and PPC was obtained.
  • PPC phosphoenolpyruvate carboxylase
  • a plasmid capable of inducing expression of ⁇ recombinase is introduced into the starting strain NZN111, so that after electroporation into a linear DNA fragment, the exonuclease inside the cell can be inhibited, the decomposition of the linear fragment can be prevented, and homologous recombination can be performed at the same time.
  • Positive screening for positive recombinants introduction of a plasmid capable of inducing the production of FLP recombinase, after induction, using a pair of plates, parallel spotting, capable of growing on non-resistant plates, but not growing on resistant plates
  • the resistant NZN111 strain has been knocked out extremely.
  • the plasmid pKD46 was electrotransferred into competent E. coli NZN111.
  • the electric shock conditions are: 200 ⁇ , 25 ⁇ , electric shock voltage 2.3 kV, and electric shock time 4 to 5 ms. After electroshock, the cells were quickly added to pre-cooled 1 mL SOC medium, cultured at 150 r/min and 30 °C for 1 h, and then plated on LB medium plates with ampicillin (amp) to screen positive transformants E. coli NZN111. (pKD46).
  • the homologous arm primer H1-P1 is upstream and the underline is a homologous fragment:
  • Reaction system Upstream and downstream primers with homology arms (100 ⁇ / ⁇ ) 0.5 ⁇ each, template DNA (100 ng/ ⁇ ) 0.5 ⁇ ; lO bufFer 5 ⁇ ; dNTPs (10 mM) each 1 L; DMSO (100 %) 2.5 ⁇ , Pyrobest DNA polymerase (2.5 U/L) l L; ddH 2 0 36/35.5 ⁇ ; total volume 50 L.
  • Reaction conditions 94 ° C, 2 min ; (94 ° C 45 sec; 50 ° C 45 sec; 72 ° C 90 sec; 10 cycles); (94 ° C 45 sec; 50 ° C 45 sec; 72 ° C 90 sec; 15 cycles); 72 °C, 5 min.
  • Upstream primer 5,- CGAGCTCATGAACTCAGTTGATTTGACCG -3';
  • the reaction conditions are: 94 ° C, 5 min; (94 ° C 45 s, 55 ° C 45 s, 72 ° C 100 s, 35 cycles); 72 °C, 10 min.
  • the purified d gene and the expression plasmid pTrc99a were digested with ⁇ icl and ⁇ , respectively, and ligated to obtain the recombinant plasmid pTrc99a-/ ⁇ Jt.
  • the agarose gel electrophoresis identification of the PCR product is shown in Figure 7; the double-digestion electrophoresis identification of the plasmid pTrc99a-pdt is shown in Figure 8.
  • This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malic enzyme to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA205 was obtained.
  • Upstream primer 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';
  • Downstream primer 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.
  • the target gene fragment was amplified by PCR using Ba ZZM MMfo genomic DNA as template.
  • the reaction conditions were: 94 ° C, 5 min ; (94 ° C 45 s, 55 ° C 45 s, 72 ° C 100 s, 35 Cycles); 72 °C, 10 min.
  • the purified amplified gene and the expression plasmid pTrc99a- were digested with H dlll and ligated, respectively, to obtain a recombinant plasmid pTrc99a- ⁇ cA-pd.
  • a single-double digestion map of the recombinant plasmid pTrc99a- / -p is shown in Figure 9.
  • the plasmid pTr C 99a- /b -p C t was introduced before the apramycin resistance was eliminated, and the competent state of the NZN 111 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • the positive transformant is Escherichia coll BA205.
  • This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malate dehydrogenase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA206 was obtained.
  • the .co/ NZNl ll strain lacking lactate dehydrogenase gene UdhA and pyruvate formate lyase gene pflB ⁇ ) was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • PPC phosphoenolpyruvate carboxylase
  • Upstream primer 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';
  • Downstream primer 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.
  • the competent strain of NZN 111 strain which has been knocked out of the phosphoenolpyruvate carboxylase (PPC) gene before the plasmid pT rC 99 a - ift-p was introduced, and the positive transformation was obtained.
  • the child is Escherichia coli BA206.
  • This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and pyruvate carboxylase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA207 was obtained.
  • the strain lacking lactate dehydrogenase gene (WM) and pyruvate formate lyase gene pflB was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out.
  • PPC phosphoenolpyruvate carboxylase
  • Upstream primer 5,- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';
  • Downstream primer 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.
  • the reaction conditions are: 94 ° C, 5 min ; (94 °C 45 s, 55 °C 45 s, 72 °C 100 s, 35 cycles); 72 °C, 10 min.
  • the purified pd gene and the expression plasmid pTrc99a-/?yc were digested with H ⁇ ffll and ligated, respectively, to obtain the recombinant plasmid pTrc99a-ro ( ⁇ d. Recombinant plasmid pTrc99a-/ ⁇ c-/7
  • the identification map is shown in Figure 11.
  • This example illustrates the comparison of the acidogenic ability of the newly constructed recombinant Escherichia coli BA204 of Example 1 with the starting strain Escherichia coli NZNl l1.
  • E. coli e n' C /u' fl BA204 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and access from the cryopreservation tube. In the flask, when the aerobic cultured cells OD 6 (K) to 0.4 to 0.6 were induced with 0.3 mM IPTG to OD 6Q . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZNl l1.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZN1 11.
  • Escherichia coli BA204 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid.
  • the two-stage fermentation method is characterized by 1% (v/v) inoculum from the cryotube into the flask.
  • aerobic cultured cells OD 6Q .
  • it is around 3 it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZN1 11.
  • Escherichia coli BA204 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means no E is detected.
  • Example 11 This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • Escherichia coli BA205 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid.
  • the two-stage fermentation method is characterized by 1% (v/v) inoculum from the frozen tube into the flask.
  • 1% (v/v) inoculum from the frozen tube into the flask.
  • Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG.
  • Q 3 or so, transfer to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and ferment for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • Escherichia coli BA205 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum from the cryotube into the flask, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • Escherichia coli c/i e n'c/ 'ii CO / BA206 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid, using a two-stage fermentation method, which is characterized by a 1% (v/v) inoculum from the frozen
  • the storage tube is connected to the triangular flask.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.
  • Escherichia coli BA206 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and is inserted into the flask from the cryotube. When aerobic cultured cells OD 6 . . It was induced to OD 6 with 0.3 mM IPTG to about 0.4 to 0.6. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + corn cob hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) ten 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.
  • Escherichia coli BA206 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum from the cryotube into the flask. Aerobic culture Body OD 6 . Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.
  • Escherichia coli BA206 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • E. coli e n' C /u' fl BA207 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and access from the cryotube.
  • a two-stage fermentation method which is characterized by 1% (v/v) inoculum and access from the cryotube.
  • the aerobic cultured cells OD 6Q () to 0.4 to 0.6 were induced with 0.3 mM IPTG to OD 6Q .
  • the aerobic phase medium was: LB + Amp (ampicillin 50 g/mL).
  • the anaerobic phase medium was: LB + xylose (20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin: 50 g / mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the original strain Escherichia coli NZN1 11.
  • Escherichia coli BA207 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and is inserted into the flask from the cryotube. When aerobic cultured cells OD 6 . Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L) decahydrate magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the starting strain Escherichia coli NZNl l l.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic stage medium is: LB+ straw straw hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g+Amp (ammonium chloride) Mycin 50 g/mL) +0.3 mM IPTGc
  • ND means not detected.
  • This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the starting strain Escherichia coli NZNl l l.
  • Escherichia coli BA207 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.
  • the aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).
  • the anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.
  • ND means no ⁇ detected

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Provided is a construction method of an escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism and the method for producing succinic acid by fermentation using the bacteria. The ATP biosynthesis pathway of escherichia coli is modified by means of molecular biology and the enzyme activity related to the pathway is over-expressed; thus the total ATP amount within escherichia coli cells is effectively increased such that the recombinant escherichia coli is able to grow using xylose metabolism, and the succinic acid synthesis efficiency is thereby significantly improved.

Description

利用木糖代谢产丁二酸大肠杆菌基因工程菌的构建方法  Method for constructing genetically engineered bacteria producing succinic acid by using xylose metabolism

技术领域 Technical field

本发明属于生物工程技术领域, 涉及利用木糖代谢产丁二酸大肠杆菌基因工程菌的构建 方法。  The invention belongs to the field of bioengineering technology, and relates to a method for constructing a genetically engineered bacterium of succinic acid using xylose metabolism.

背景技术 Background technique

丁二酸 (succinic acid) 又称琥珀酸, 被广泛应用于医药、 农药、 染料、 香料、 油漆、 食 品和塑料等行业, 作为 C4平台化合物, 可用于合成 1, 4-丁二醇、 四氢呋喃、 γ-丁内酯等有 机化学品以及聚丁二酸丁二醇酯(PBS)类生物可降解材料, 被美国能源部认为是未来 12种 最有价值的生物炼制产品之一。  Succinic acid (Succinic acid), also known as succinic acid, is widely used in the pharmaceutical, pesticide, dye, fragrance, paint, food and plastic industries. As a C4 platform compound, it can be used to synthesize 1,4-butanediol, tetrahydrofuran, Organic chemicals such as γ-butyrolactone and polybutylene succinate (PBS) biodegradable materials are considered by the US Department of Energy to be one of the 12 most valuable biorefining products in the future.

丁二酸的生产方法主要包括化学合成法和微生物发酵法, 利用微生物发酵法转化可再生 资源(葡萄糖、 木糖等), 由于原料来源广泛且价格低廉, 污染小, 环境友好, 且在发酵过程 中可以吸收固定 C02, 能有效缓解温室效应, 开辟了温室气体二氧化碳利用的新途径, 今年 来成为研究的热点。 丁二酸的生产菌株主要集中在 Anaerobiospirillum succiniciproducens , Actinobacillus succinogenes ^ Mannheimia succiniciproducens^重组谷氛酸棒杆菌和重组 E.coIi。 利用野生菌株生产丁二酸虽然获得了较高的产物浓度, 但培养过程培养基成本较高, 且甲酸、 乙酸等副产物积累较多, 阻碍了其工业化进程。 E.coli 由于遗传背景清楚、 易操作、 易调控、 培养基要求简单和生长迅速等优点, 近年来被广泛用于研究以获得产丁二酸优秀菌株。 The production method of succinic acid mainly includes chemical synthesis method and microbial fermentation method, and uses microbial fermentation method to convert renewable resources (glucose, xylose, etc.), due to wide source and low price of raw materials, low pollution, environmental friendliness, and in the fermentation process. It can absorb fixed C0 2 , which can effectively alleviate the greenhouse effect and open up a new way of utilizing greenhouse gas carbon dioxide. This year has become a research hotspot. The production strain of succinic acid is mainly concentrated in Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes ^ Mannheimia succiniciproducens ^ recombinant Corynebacterium glutamicum and recombinant E.coIi. Although the production of succinic acid by wild strains has obtained a higher product concentration, the culture medium cost is higher, and by-products such as formic acid and acetic acid accumulate more, hindering the industrialization process. E.coli has been widely used in recent years to obtain excellent strains of succinic acid production due to its clear genetic background, easy operation, easy regulation, simple medium requirements and rapid growth.

£.CO/野生菌株生产丁二酸虽然获得了较高的产物浓度,但培养过程培养基成本较高,且 甲酸、 乙酸等副产物积累较多, 因此可以敲除或失活其中的乳酸脱氢酶 (LDH)基因和丙酮酸 甲酸裂解酶 (PFL)基因活性以减少副产物的生成。但是, 由于敲除了 PFL基因, 导致菌株不能 生产乙酸,从而使伴随乙酸生成的 ATP减少,最终导致重组大肠杆菌不能利用木糖代谢生长, 并且生产丁二酸。 Although the CO /wild strain produces succinic acid, although higher product concentration is obtained, the culture medium cost is higher, and by-products such as formic acid and acetic acid accumulate more, so the lactate can be knocked out or inactivated. Hydrogenase (LDH) gene and pyruvate formate lyase (PFL) gene activity to reduce by-product formation. However, the knockdown of the PFL gene results in the inability of the strain to produce acetic acid, thereby reducing the ATP accompanying the production of acetic acid, eventually leading to the inability of recombinant E. coli to utilize xylose metabolic growth and to produce succinic acid.

玉米芯是农业生产中比较常见的废弃物, 由于其成分含有大量纤维素, 因此其水解液对 微生物发酵来说, 是一种很好的可持续利用的绿色碳源, 但其水解液含有高浓度木糖, 因此 大肠杆菌 NZN111不能利用玉米芯水解液发酵生产丁二酸。姜岷等将玉米芯按料液比 1: 5 (质 量体积比)配制玉米芯料液, 物料粒径 250〜380μηι, H2S04用量 3% (;体积分数), 水解温度 126 °C , 反应时间 215 h, 利用活性炭吸附及 Ca (OH) 2中和等方式, 对玉米芯多组分糖液进行 脱毒脱盐处理, 总糖质量浓度为 50 g/L, 其中木糖占 80%以上。 Corn cob is a common waste in agricultural production. Because its composition contains a lot of cellulose, its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high The concentration of xylose, therefore E. coli NZN111 can not be fermented using corn cob hydrolysate to produce succinic acid. Jiang Yan et al. prepared corn cob liquid with a ratio of 1:5 (mass to volume ratio) of corn cob, material size 250~380μηι, H 2 S0 4 dosage 3% (volume fraction), hydrolysis temperature 126 °C, The reaction time was 215 h, and the corncob multi-component sugar solution was detoxified and desalted by activated carbon adsorption and Ca(OH) 2 neutralization. The total sugar concentration was 50 g/L, and xylose accounted for more than 80%. .

稻草秸秆是重要的一类可再生生物质资源。 目前, 除了在造纸业工业方面的利用, 绝大 多数被废弃, 严重浪费了资源并且污染了环境。 其主要成分是纤维素、 半纤维素和木质素, 因此其水解液对微生物发酵来说, 是一种很好的可持续利用的绿色碳源, 但其水解液含有高 浓度木糖, 因此不能利用木糖的大肠杆菌菌株不能利用稻草秸秆水解液发酵生产丁二酸, 陶 文沂等通过稀硫酸 121 °C处理稻草秸秆 1 h, 再用 20 g/L的 NaOH于 121 °C处理秸秆 1 h, 葡 萄糖和木糖二者总质量浓度都达 50 g/L左右。  Straw straw is an important class of renewable biomass resources. At present, most of them are discarded except for the use in the paper industry, which wastes resources and pollutes the environment. Its main components are cellulose, hemicellulose and lignin, so its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high concentration of xylose, so it can not E. coli strains using xylose could not be fermented by straw straw hydrolysate to produce succinic acid. Tao Wenqi et al. treated straw straw with dilute sulfuric acid at 121 °C for 1 h, and treated 20 g/L NaOH at 121 °C for 1 h. The total mass concentration of both glucose and xylose is about 50 g/L.

甘蔗渣是甘蔗制糖时榨糖之后剩下的主要成分, 因此其水解液对微生物发酵来说, 是一 种很好的可持续利用的绿色碳源, 但其水解液含有高浓度木糖, 因此不能利用木糖的大肠杆 菌菌株不能利用稻草秸秆水解液发酵生产丁二酸,约含有 50%的纤维素通过粉碎以及碱 /氧化 法预处理可得到总糖质量为 50 g/L, 其中木糖占 80%以上。  Bagasse is the main component left after sugar cane sugar production. Therefore, its hydrolyzate is a good sustainable green carbon source for microbial fermentation, but its hydrolyzate contains high concentration of xylose. Therefore, the E. coli strain which cannot utilize xylose can not be fermented to produce succinic acid by using straw straw hydrolysate, and about 50% of cellulose can be obtained by pulverization and alkali/oxidation pretreatment to obtain a total sugar mass of 50 g/L, wherein wood Sugar accounts for more than 80%.

在大肠杆菌磷酸烯醇式丙酮酸通过磷酸烯醇式丙酮酸羧化酶生成草酰乙酸, 在此过程中 没有 ATP的生成, 但是在

Figure imgf000003_0001
rato fc中, 磷酸烯醇式丙酮酸是通过磷酸烯醇式丙酮酸羧 化激酶生成草酰乙酸的, 在此过程中有 ATP的生成, 并且 Millard等在大肠杆菌中过量表达 E. coli ppc和 pck, 研究发现过量表达/ 可以使琥珀酸作为混合酸发酵的主要产物, 且产量 较出发菌株提高 3.5倍, 而过量表达 对发酵结果没有影响, 但在^ C缺陷菌株中, 的 过量表达能够提高琥珀酸的产量。 In Escherichia coli phosphoenolpyruvate, oxaloacetate is produced by phosphoenolpyruvate carboxylase, in the process without ATP formation, but in
Figure imgf000003_0001
In rato fc, phosphoenolpyruvate produces oxaloacetate by phosphoenolpyruvate carboxylation kinase, in which ATP is produced, and Millard et al. overexpress E. coli ppc and E. coli. Pck, the study found that overexpression / can make succinic acid as the main product of mixed acid fermentation, and yield The expression was 3.5 times higher than that of the original strain, and the overexpression had no effect on the fermentation result, but in the C-deficient strain, the overexpression could increase the yield of succinic acid.

发明内容 Summary of the invention

本发明的技术目的在于提供了一种基于 ATP生物合成系统改造后的大肠杆菌菌株的构建 方法, 达到菌株的构建方法简单方便, 构建得到的菌株发酵方法简单可行, 易于工业化, 产 酸能力强的目的, 从而大大降低了生产成本, 提高经济效益。  The technical aim of the present invention is to provide a method for constructing an Escherichia coli strain based on ATP biosynthesis system, and the method for constructing the strain is simple and convenient, and the fermentation method of the constructed strain is simple and feasible, easy to industrialize, and capable of producing acid. The purpose is to greatly reduce production costs and improve economic efficiency.

为实现本发明目的, 本发明采用以下技术方案。  In order to achieve the object of the present invention, the present invention adopts the following technical solutions.

利用木糖代谢产丁二酸大肠杆菌基因工程菌的构建方法, 其特征在于包括如下步骤: A method for constructing a succinic acid Escherichia coli genetically engineered bacterium by utilizing xylose metabolism, comprising the steps of:

(1)以缺乏乳酸脱氢酶基因 丙酮酸甲酸裂解酶基因( Ζβ)活性的 .cc^'NZNlll 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC)基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株; (1) The .cc^'NZNlll strain lacking the lactate dehydrogenase gene pyruvate formate lyase gene (Ζβ) activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. Competent strains lacking WM, pflB and PPC;

(2) 单独纯化扩增出磷酸烯醇式丙酮酸羧化激酶 pck 基因, 或者纯化扩增出磷酸烯 醇式丙酮酸羧化激酶 pck~)基因, 以及选择自苹果酸酶 G/ )基因、 苹果酸脱氢酶 mdh 基因或丙酮酸羧化酶 (pyc)基因这三种基因中的一种, 构建得到单独过量表达磷酸烯醇式丙 酮酸羧化激酶, 或者过量表达磷酸烯醇式丙酮酸羧化激酶, 以及选择自苹果酸酶、 苹果酸脱 氢酶或丙酮酸羧化酶这三种酶中的一种的表达质粒;  (2) Purification of the phosphoenolpyruvate carboxylase pck gene, or purification and amplification of the phosphoenolpyruvate carboxylase pck~) gene, and selection of the malic enzyme G/) gene, One of three genes, the malate dehydrogenase mdh gene or the pyruvate carboxylase (pyc) gene, is constructed to overexpress phosphoenolpyruvate carboxylase alone or to overexpress phosphoenolpyruvate. a carboxylated kinase, and an expression plasmid selected from one of three enzymes, malic enzyme, malate dehydrogenase or pyruvate carboxylase;

(3)将步骤 (2) 所述的质粒导入步骤 (1) 得到的感受态菌株, 获得阳性转化子; (3) introducing the plasmid described in the step (2) into the competent strain obtained in the step (1) to obtain a positive transformant;

(4)利用歩骤 (3) 的阳性转化子单独过量表达磷酸烯醇式丙酮酸羧化激酶, 或者过量 表达磷酸烯醇式丙酮酸羧化激酶, 以及选择自苹果酸酶、 苹果酸脱氢酶或丙酮酸羧化酶这三 种酶中的一种, 恢复其在厌氧条件下代谢木糖的能力, 得到可利用木糖代谢产丁二酸基因工 程菌。 (4) Excessive overexpression of phosphoenolpyruvate carboxylase by positive transformants of step (3), or overexpression of phosphoenolpyruvate carboxylase, and dehydrogenation from malic enzyme and malate One of the three enzymes, enzyme or pyruvate carboxylase, restores its ability to metabolize xylose under anaerobic conditions, and obtains genetically engineered bacteria producing succinic acid by utilizing xylose metabolism.

具体的, 利用本发明所述的上述方法可以细分为下述几个具体方法。  Specifically, the above method described in the present invention can be subdivided into the following specific methods.

A、 过量表达磷酸烯醇式丙酮酸羧化激酶, 得到能够高效利用木糖生长并产丁二酸的大 肠杆菌 Escherichia coli BA204:  A. Excessive expression of phosphoenolpyruvate carboxylase to obtain Escherichia coli BA204 capable of efficiently utilizing xylose growth and producing succinic acid:

以缺乏乳酸脱氢酶基因 ldhA、, 丙酮酸甲酸裂解酶基因 pflB 活性的 E.coli NZN111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC)基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株;  The E.coli NZN111 strain lacking lactate dehydrogenase gene ldhA and pyruvate formate lyase gene pflB activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out, which resulted in the lack of WM. Competent strains of pflB and PPC;

合成一对 5'端带有酶切位点的引物, 以 BadU s^rifc基因组 DNA为模板, 纯化扩增 出的 基因后, 表达质粒 pTrc99a用与引物所设计的酶切位点一致的酶双酶切、 连接获得 重组质粒 pTrc99a- ct;  A pair of primers with a restriction enzyme site at the 5' end were synthesized, and the amplified gene was purified by using BadU s^rifc genomic DNA as a template. The expression plasmid pTrc99a was doubled with the enzyme cleavage site designed by the primer. Digestion, ligation to obtain recombinant plasmid pTrc99a- ct;

将质粒 ρΤκ99ίΐ-;7^导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化酶 (PPC) 基因的 NZN111菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA204;  The plasmid ρΤκ99ίΐ-;7^ was introduced to eliminate the apramycin resistance, and the competent state of the NZN111 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. The positive transformant obtained was Escherichia coli BA204. ;

利用 Escherichia coli BA204过量表达磷酸烯醇式丙酮酸羧化激酶, 恢复其在厌氧条件下 代谢木糖的能力。 重组质粒 ρΤκ^^-ρ 的构建图谱如图 3所示。  Escherichia coli BA204 was used to overexpress phosphoenolpyruvate carboxylase to restore its ability to metabolize xylose under anaerobic conditions. The constructed map of the recombinant plasmid ρΤκ^^-ρ is shown in Fig. 3.

B、 过量共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸酶, 得到能够高效利用木糖生长并 产丁二酸的大肠杆菌 Escherichia coli BA205:  B. Excessive co-expression of phosphoenolpyruvate carboxylase and malic enzyme to obtain Escherichia coli BA205 which can efficiently utilize xylose to grow and produce succinic acid:

以缺乏乳酸脱氢酶基因 (腸'), 丙酮酸甲酸裂解酶基因 (pflB) 活性的 E.coli NZN111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC)基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株;  The E. coli NZN111 strain lacking the lactate dehydrogenase gene (intestine') and the pyruvate formate lyase gene (pflB) activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. Simultaneous lack of competent strains of WM, pflB and PPC;

合成一对 5'端带有相同酶切位点的引物, 以 ^^7/^ ^^' 基因组 DNA为模板, 纯化 扩增出的 pck基因后, 已构建的重组质粒 pTrC99a- o 用与引物所设计的酶切位点一致的酶 单酶切、 连接获得重组质粒 pTrc99a-Ji h -;jd:; 将质粒 pTrC99a-^ l-pd 导入之前消除安普霉素抗性, 已敲除瞵酸烯醇式丙酮酸羧化酶 (PPC)基因的 NZN1 11菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA205 ; A pair of primers carrying the same restriction site at the 5' end were synthesized, and the amplified ppk gene was purified by using ^^7/^^^' genomic DNA as a template, and the recombinant plasmid pTr C 99a- o was constructed. The enzyme is digested with the enzyme cleavage site designed by the primer, and the recombinant plasmid pTrc99a-Ji h -; jd:; The competent transformant obtained by introducing the plasmid pT rC 99a-^ l-pd to eliminate apramycin resistance, knocked out the NZN1 11 strain of the decanoic pyruvate carboxylase (PPC) gene, and obtained the positive transformant That is Escherichia coli BA205;

利用 Escherichia coli BA205共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸酶, 恢复其在厌 氧条件下代谢木糖的能力。 重组质粒 ρΤ¾9 - -/ Λ的构建图谱如图 4所示。  Escherichia coli BA205 was used to co-express phosphoenolpyruvate carboxylase and malic enzyme to restore its ability to metabolize xylose under anaerobic conditions. The construction map of the recombinant plasmid ρΤ3⁄49 - -/ Λ is shown in Fig. 4.

C、 过量共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸脱氢酶, 使其能够高效利用木糖生 长并产丁二酸, 获得大肠杆菌 Escherichia coli BA206 :  C. Excessive co-expression of phosphoenolpyruvate carboxylase and malate dehydrogenase enables efficient use of xylose to produce succinic acid to obtain Escherichia coli BA206:

以缺乏乳酸脱氢酶基因 (WM), 丙酮酸甲酸裂解酶基因 (ρ/? ) 活性的 E.coli NZN111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株;  The E.coli NZN111 strain lacking lactate dehydrogenase gene (WM) and pyruvate formate lyase gene (ρ/?) was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. Obtaining competent strains lacking both WM, pflB and PPC;

合成一对 5 '端带有相同酶切位点的引物, 以 ^^'¾« ^^7^基因组 DNA为模板, 纯化 扩增出的 pck基因后, 已构建的重组质粒 pTrc99a-™ft用与引物所设计的酶切位点一致的酶 单酶切、 连接获得重组质粒 pTrc99a-wtt i-;?d ;  A pair of primers carrying the same restriction site at the 5' end were synthesized, and the amplified ppk gene was purified by using ^^'3⁄4« ^^7^ genomic DNA as a template, and the constructed recombinant plasmid pTrc99a-TMft was used. The enzyme was digested with the enzyme cleavage site designed by the primer, and the recombinant plasmid pTrc99a-wtt i-;?d was obtained;

将质粒 pTrc99a-™¾-;7C t导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化酶 (PPC)基因的 NZN1 11菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA206; The plasmid pT rc 99 a -TM3⁄4-;7 C t was introduced before the apramycin resistance was eliminated, and the competent state of the NZN1 11 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. The positive transformant is Escherichia coli BA206;

利用 Escherichia coli BA206共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸脱氢酶, 恢复其 在厌氧条件下代谢木糖的能力。 重组质粒 ρΎκ99 dh-pck的构建图谱如图 5所示。  Escherichia coli BA206 was used to co-express phosphoenolpyruvate carboxylase and malate dehydrogenase to restore its ability to metabolize xylose under anaerobic conditions. The construction map of the recombinant plasmid ρΎκ99 dh-pck is shown in Fig. 5.

D、 过量共表达磯酸烯醇式丙酮酸羧化激酶和丙酮酸羧化酶, 使其能够高效利用木糖生 长并产丁二酸, 获得大肠杆菌 Escherichia coli BA207 :  D. Excessive co-expression of the acid-enolpyruvate carboxylase and pyruvate carboxylase enables the efficient use of xylose to produce succinic acid to obtain Escherichia coli BA207:

以缺乏乳酸脱氢酶基因 IdhA , 丙酮酸甲酸裂解酶基因 ipflB 活性的 E.coli NZN111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株;  The E.coli NZN111 strain lacking lactate dehydrogenase gene IdhA and pyruvate formate lyase gene ipflB activity was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out, which resulted in the lack of WM and pflB. Competent strains of PPC;

合成一对 5 '端带有相同酶切位点的引物, 以 ad¾«™M 基因组 DNA为模板, 纯化 扩增出的;《*基因后, 已构建的重组质粒 pTrc99a-;?yc用与引物所设计的酶切位点一致的酶单 酶切、 连接获得重组质粒 pTrc99a-/^c-pcJt; A pair of primers carrying the same restriction site at the 5' end were synthesized and purified by using ad3⁄4«TMM genomic DNA as a template; after the * gene, the constructed recombinant plasmid pT rc 99 a -;? yc The recombinant plasmid pTrc99a-/^c-pcJt was obtained by single enzyme digestion and ligation with the enzyme cleavage site designed by the primer;

将质粒 ρΤ ^^-ρ^-ρ 导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化酶 PPC)基因的 NZN1 11菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA207;  The plasmid ρΤ ^^-ρ^-ρ was introduced before the introduction of the NZN1 11 strain which amplifies the resistance to apramycin, and the phosphoenolpyruvate carboxylase PPC gene was knocked out. The positive transformant obtained was Escherichia coli BA207;

利用 Escherichia coli BA207共表达磷酸烯醇式丙酮酸羧化激酶和丙酮酸羧化酶, 恢复其 在厌氧条件下代谢木糖的能力。 重组质粒 ρΤκ;99 - ^-Ρ 的构建图谱如图 6所示。 Escherichia coli BA207 was used to co-express phosphoenolpyruvate carboxylase and pyruvate carboxylase to restore its ability to metabolize xylose under anaerobic conditions. The constructed map of the recombinant plasmid ρΤκ;99 - ^- Ρ is shown in Fig. 6.

本发明的有益效果在于:  The beneficial effects of the invention are:

首先, 厌氧发酵过程中产大量诸如乙酸等对菌株有毒害作用的副产物, 因此考虑两阶段 发酵方式, 有氧阶段提高生物量, 厌氧阶段进行产酸发酵。也可以选择性地采用膜分离技术, 达到分离菌体的目的,再进而用于厌氧发酵。具体步骤如下:采用两阶段发酵模式,划线 -80°C 冻存管保藏的菌液到含有氨苄青霉素的平板, 挑取平板上长出的单菌落到 5 ml LB培养基的 试管, 1 % ( v/v)接种量接入三角瓶中, 当有氧培养菌体 OD6。。至 0.8-1.0左右时用 0.3 mM的 IPTG诱导至 OD6M=3左右时, 按接种量 10%转接至血清瓶中厌氧发酵。发酵结果表明, 新构 建的和大肠杆菌 ATP生物合成途径有关的基因工程菌 £^ ^π·ί¾·α coli BA 204、 Escherichia coli BA 205、 Escherichia coli BA 206和 Escherichia coli BA 207恢复了厌氧条件下代谢木糖的能 力, 并高效利用木糖产丁二酸。 First, in the anaerobic fermentation process, a large amount of by-products such as acetic acid which are toxic to the strain are produced, so that the two-stage fermentation method is considered, the aerobic phase increases the biomass, and the anaerobic phase performs the acidogenic fermentation. Membrane separation technology can also be selectively employed to achieve the purpose of isolating the cells, and then used for anaerobic fermentation. The specific steps are as follows: using a two-stage fermentation mode, the bacteria liquid stored in the cryotube-80°C cryotube is applied to the plate containing ampicillin, and the single colony grown on the plate is picked into the test tube of 5 ml LB medium, 1%. (v/v) Inoculum size was added to the flask, when aerobic cultured cells were OD 6 . . When induced to 0.3 mM IPTG to about OD 6M = 3 at about 0.8-1.0, the anaerobic fermentation was carried out in a serum bottle at 10% of the inoculum. The results of the fermentation indicated that the newly constructed genetically engineered bacteria associated with the E. coli ATP biosynthesis pathway restored anaerobic conditions by £^π·ί3⁄4·α coli BA 204, Escherichia coli BA 205, Escherichia coli BA 206 and Escherichia coli BA 207. The ability to metabolize xylose, and the efficient use of xylose to produce succinic acid.

其次, 本发明通过分子生物学手段改造大肠杆菌的 ATP生物合成途径, 提高 ATP供给, 补充木糖转运和代谢过程中的能量供给, 使重组大肠杆菌能够持续利用木糖生长并使其高效 合成丁二酸的方法未见公开, 而这种应用将大大推进丁二酸产业的进步和发展。  Secondly, the present invention modifies the ATP biosynthesis pathway of Escherichia coli by molecular biological means, increases the supply of ATP, supplements the energy supply in the xylose transport and metabolism process, enables the recombinant Escherichia coli to continue to utilize xylose growth and efficiently synthesize it. The method of diacid has not been disclosed, and this application will greatly advance the progress and development of the succinic acid industry.

附图说明 图 1线性 DNA片段的电泳鉴定图。 DRAWINGS Figure 1. Electrophoretic identification of a linear DNA fragment.

图 2同源重组阳性重组子的电泳鉴定图。  Figure 2. Electrophoretic identification of homologous recombinant positive recombinants.

图 3 重组质粒 pTrc99a-p 的构建图谱。  Figure 3. Construction map of the recombinant plasmid pTrc99a-p.

图 4重组质粒 pTrc99a- -/ ^的构建图谱。  Figure 4. Construction map of recombinant plasmid pTrc99a--/^.

图 5重组质粒 pTrc99a-m^-prtt的构建图谱。  Figure 5. Construction map of the recombinant plasmid pTrc99a-m^-prtt.

图 6重组质粒 ρΤκ;99 - }^-ρ^的构建图谱。  Figure 6. Construction of recombinant plasmid ρΤκ;99 - }^-ρ^.

图 7 PCR产物 pck的琼脂糖凝胶电泳鉴定图。  Figure 7 Agarose gel electrophoresis identification of the PCR product pck.

图 8重组质粒 ρΤΐΐ99&-ρ 的单双酶切鉴定图。  Figure 8. Identification of the recombinant plasmid ρΤΐΐ99&-ρ by single and double digestion.

图 9重组质粒 pTrc99a-^ 4-p 的单双酶切鉴定图。  Figure 9. Single-double digestion map of recombinant plasmid pTrc99a-^ 4-p.

图 10重组质粒 pTrc99a-mi -P(^的单双酶切鉴定图。 Figure 10 is a single double-digestion identification map of the recombinant plasmid pTrc99a-mi- P (^.

图 11重组质粒 pTrc99a-;^c-pd的单双酶切鉴定图。  Figure 11 is a single-double digestion map of the recombinant plasmid pTrc99a-;^c-pd.

具体实施方式 detailed description

下面的实施例对本发明作详细说明, 但对本发明没有限制。  The following examples are illustrative of the invention but are not intended to limit the invention.

本发明所述的安普霉素抗性基因的来源是: pIJ773, 获得自南京师范大学邵蔚蓝教授处。 本发明所述的能够诱导表达 λ重组酶的质粒的来源是: pKD46, 购自 Introvegen公司。 本发明所述的能够诱导产生 FLP重组酶的质粒的来源是: pCP20, 购自 Introvegen公司。 本发明所述的 Bacillus subtilis基因组的来源是: 购自中国典型培养物保藏中心。  The source of the apramycin resistance gene of the present invention is: pIJ773, obtained from Professor Shao Weilan of Nanjing Normal University. The source of the plasmid capable of inducing expression of the lambda recombinase of the present invention is: pKD46, available from Introvegen. The source of the plasmid capable of inducing the production of FLP recombinase according to the present invention is: pCP20, purchased from Introvegen. The source of the Bacillus subtilis genome of the present invention is: purchased from the China Center for Type Culture Collection.

本发明所述的表达质粒用 pTrc99a的来源是: 购自 Introvegen公司。  The source of pTrc99a for the expression plasmid of the present invention is: purchased from Introvegen.

本发明所述的出发菌株: Ε. ΝΖΝ111的感受态菌株的来源有两处:  The starting strain of the present invention: Ε. The source of the competent strain of ΝΖΝ111 has two places:

( 1 ) Biotechnol Bioeng, 2001,74:89〜95。 申请人首先通过査阅到该生物材料的上述文献 出处, 并联系了发表人系美国芝加哥大学的 David P. Clark教授, 并邮件请求其赠与该生物材 料, 并免费获得了该生物材料; 且申请人保证从本申请日起二十年内向公众发放该生物材料;  (1) Biotechnol Bioeng, 2001, 74: 89-95. The applicant first consulted the source of the above-mentioned literature on the biological material, and contacted the publisher, Professor David P. Clark of the University of Chicago, and requested the gift of the biological material, and obtained the biological material free of charge; The person guarantees that the biological material will be distributed to the public within 20 years from the date of this application;

( 2 ) 该生物材料还在中国专利 (申请号 96198547.X, 申请日 1996.10.31, 授权日 2003 年 1月 1日, 授权公告号 CN1097632C ) 的专利文献中公开并获得授权。  (2) The biological material is also disclosed and authorized in the patent documents of the Chinese patent (Application No. 96198547.X, Application Date 1996.10.31, Authorization Date January 1, 2003, Authorization Bulletin No. CN1097632C).

本发明所述的引物的设计及合成: 自行设计并外包金斯瑞生物技术公司合成。  The design and synthesis of the primers of the present invention: self-designed and outsourced synthesis by Kingsray Biotech.

实施例 1  Example 1

本实施例说明构建过量表达磷酸烯醇式丙酮酸羧化激酶的表达质粒, 恢复重组菌株在厌 氧条件下代谢木糖的能力, 得到菌株 Escherichia coli BA204。  This example illustrates the construction of an expression plasmid overexpressing phosphoenolpyruvate carboxylase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions to obtain the strain Escherichia coli BA204.

1、 以缺乏乳酸脱氢酶基因(WM), 丙酮酸甲酸裂解酶基因 pflB~)活性的 .co/ NZNl l l 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株。  1. The .co/ NZNl ll strain lacking lactate dehydrogenase gene (WM) and pyruvate formate lyase gene pflB~) was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. A competent strain lacking both WM, pflB and PPC was obtained.

利用同源重组技术敲除磷酸烯醇式丙酮酸羧化酶 (PPC)基因: 以两侧带有 FRT位点的安 普霉素抗性基因为模板, 利用高保真 PCR扩增系统, 并设计两端带有 PPC同源片段的扩增 引物, 成功扩增出线性 DNA同源片段;  Knockout of phosphoenolpyruvate carboxylase (PPC) gene by homologous recombination technique: using a high-fidelity PCR amplification system with an apramycin resistance gene flanked by FRT sites as a template Amplification primers with PPC homologous fragments at both ends, and linear DNA homologous fragments were successfully amplified;

在出发菌株 NZN111中导入能够诱导表达 λ重组酶的质粒,使在电转入线性 DNA片段后, 可以抑制菌体内部的核酸外切酶, 防止线性片段的分解, 同时进行同源重组, 通过抗性筛选 获得阳性重组子; 导入能够诱导产生 FLP重组酶的质粒, 在诱导后, 利用一对平板, 进行平 行点样, 能够在无抗性平板上生长, 但不能在抗性平板上生长的均极为已经敲除抗性的 NZN111菌株。  A plasmid capable of inducing expression of λ recombinase is introduced into the starting strain NZN111, so that after electroporation into a linear DNA fragment, the exonuclease inside the cell can be inhibited, the decomposition of the linear fragment can be prevented, and homologous recombination can be performed at the same time. Positive screening for positive recombinants; introduction of a plasmid capable of inducing the production of FLP recombinase, after induction, using a pair of plates, parallel spotting, capable of growing on non-resistant plates, but not growing on resistant plates The resistant NZN111 strain has been knocked out extremely.

具体的方法:  Specific method:

( 1 )利用 LB培养基, 于 37 °C、 有氧条件下培养大肠杆菌 NZN111至 OD6QQ=0.4〜0.6, 制备成电转感受态。 (2 )将质粒 pKD46电转入感受态的大肠杆菌 NZN111。 电击条件为: 200 Ω, 25 μΡ, 电 击电压 2.3 kV,电击时间 4〜5 ms。电击后迅速将菌体加入预冷 1 mL的 SOC培养基, 150 r/min、 30°C培养 1 h之后涂布于带氨苄青霉素 (amp)的 LB 培养基平板筛选出阳性转化子大肠杆菌 NZN111 (pKD46)。 (1) Escherichia coli NZN111 was cultured under aerobic conditions at 37 ° C under an aerobic condition to an OD 6 QQ = 0.4 to 0.6 to prepare an electrotransformed competent state. (2) The plasmid pKD46 was electrotransferred into competent E. coli NZN111. The electric shock conditions are: 200 Ω, 25 μΡ, electric shock voltage 2.3 kV, and electric shock time 4 to 5 ms. After electroshock, the cells were quickly added to pre-cooled 1 mL SOC medium, cultured at 150 r/min and 30 °C for 1 h, and then plated on LB medium plates with ampicillin (amp) to screen positive transformants E. coli NZN111. (pKD46).

( 3 )在 LB培养基中加入 10 mM的 L-阿拉伯糖, 于 30°C下诱导质粒 pKD46表达出 λ 重组酶, 制成电转感受态。  (3) 10 mM L-arabinose was added to LB medium, and plasmid pKD46 was induced to express λ recombinase at 30 ° C to prepare electroporation.

(4 ) 以两侧带有 FRT位点的安普霉素抗性基因为模板, 利用高保真 PCR扩增系统, 以 质粒 PIJ773为模板,并设计两端带有 PPC同源片段的扩增引物,扩增出线性 DNA同源片段, 引物序列如下:  (4) Using the apramycin resistance gene with FRT locus on both sides as a template, using high-fidelity PCR amplification system, using plasmid PIJ773 as a template, and designing amplification primers with PPC homologous fragments at both ends , a linear DNA homologous fragment was amplified, and the primer sequence was as follows:

上游带同源臂引物 H1-P1 , 下划线为同源片段:  The homologous arm primer H1-P1 is upstream and the underline is a homologous fragment:

GGGATCCGTCGACC-3 '。 GGGATCCGTCGACC-3 '.

下游带同源臂引物 Η2-Ρ2, 下划线为同源片段:  Downstream with the homology arm primer Η2-Ρ2, underlined as a homologous fragment:

GCTGGAGCTGCTTC-3 '。 GCTGGAGCTGCTTC-3 '.

反应体系: 带同源臂的上下游引物 (100 ριηοΐ/μί)各 0.5 μ^, 模板 DNA(100 ng/μί) 0.5 μί; lO bufFer 5 μί; dNTPs (10 mM)各 1 L; DMSO(100%) 2.5 μ^, Pyrobest DNA聚合酶 (2.5 U/ L)l L; ddH20 36/35.5 μί; 总体积 50 L。 Reaction system: Upstream and downstream primers with homology arms (100 ριηοΐ/μί) 0.5 μ^ each, template DNA (100 ng/μί) 0.5 μί; lO bufFer 5 μί; dNTPs (10 mM) each 1 L; DMSO (100 %) 2.5 μ^, Pyrobest DNA polymerase (2.5 U/L) l L; ddH 2 0 36/35.5 μί; total volume 50 L.

反应条件: 94 °C , 2 min; (94 °C 45 sec; 50°C 45 sec; 72 °C 90 sec; 10个循环); (94 °C 45 sec; 50 °C 45 sec; 72 °C 90 sec; 15个循环); 72 °C , 5 min。 Reaction conditions: 94 ° C, 2 min ; (94 ° C 45 sec; 50 ° C 45 sec; 72 ° C 90 sec; 10 cycles); (94 ° C 45 sec; 50 ° C 45 sec; 72 ° C 90 sec; 15 cycles); 72 °C, 5 min.

线性 DNA片段的鉴定如图 2。  The identification of linear DNA fragments is shown in Figure 2.

( 5 ) 电转线性 DNA片段至已诱导表达 λ重组酶的大肠杆菌 NZNl l l(pKD46)感受态, 并涂 布于带安普霉素的 LB平板筛选出阳性重组子, 并进行了 PCR鉴定, 电泳图如图 3所示。  (5) electrotransformed linear DNA fragment to E. coli NZN1 ll (pKD46) competent form that has been induced to express λ recombinase, and coated on LB plate with apramycin to screen positive recombinants, and PCR identification, electrophoresis The figure is shown in Figure 3.

( 6 ) 阳性重组子制成感受态后倒入能诱导表达 FLP重组酶的质粒 pCP20, 于 42 °C热激表 达 FLP重组酶后即可消除安普霉素抗性。 利用一对平板, 进行平行点样, 能够在无抗性平板 上生长, 但不能在抗性平板上生长的均极为已经敲除抗性的菌株。  (6) After the positive recombinant was made into a competent state, pCP20, which can induce the expression of FLP recombinase, was inverted, and the resistance to apramycin was eliminated after heat-excited FLP recombinase at 42 °C. Using a pair of plates, parallel-like, can grow on non-resistant plates, but can not grow on resistant plates, which are extremely resistant to knockout.

2、 构建过量表达磷酸烯醇式丙酮酸羧化激酶的表达质粒, 其过程包括:  2. Constructing an expression plasmid overexpressing phosphoenolpyruvate carboxylase, the process comprising:

( 1 ) 合成带有 ^JCI和 Xbal酶切位点的引物,  (1) synthesizing primers with ^JCI and Xbal restriction sites,

上游引物: 5,- CGAGCTCATGAACTCAGTTGATTTGACCG -3';  Upstream primer: 5,- CGAGCTCATGAACTCAGTTGATTTGACCG -3';

下游引物: 5'- GCTCTAGAGCATTCCGTCAATTAAAACAAG -3Ό  Downstream primer: 5'- GCTCTAGAGCATTCCGTCAATTAAAACAAG -3Ό

(2 ) 以 «7/^ «/^7 基因组 DNA为模板, PCR扩增目的基因片段, 反应条件为: 94°C, 5 min; (94 °C 45 s, 55 °C 45 s, 72 °C 100 s, 35个循环); 72 °C , 10 min。 纯化扩增出的 d基因和 表达质粒 pTrc99a分别用 ^icl和 βΙ双酶切、连接获得重组质粒 pTrc99a-/^Jt。 PCR产物 的琼 脂糖凝胶电泳鉴定图如图 7所示; 质粒 pTrc99a-pdt的双酶切电泳鉴定如图 8所示。  (2) PCR amplification of the target gene fragment using the «7/^ «/^7 genomic DNA as a template, the reaction conditions are: 94 ° C, 5 min; (94 ° C 45 s, 55 ° C 45 s, 72 ° C 100 s, 35 cycles); 72 °C, 10 min. The purified d gene and the expression plasmid pTrc99a were digested with ^icl and βΙ, respectively, and ligated to obtain the recombinant plasmid pTrc99a-/^Jt. The agarose gel electrophoresis identification of the PCR product is shown in Figure 7; the double-digestion electrophoresis identification of the plasmid pTrc99a-pdt is shown in Figure 8.

3、将质粒 pTrC99a-pCfe导入之前消除安普霉素抗性,已敲除磷酸烯醇式丙酮酸羧化酶 (; PPC) 基因的 NZN111菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA204。 3. The importation of the plasmid pT rC 99 a -p C fe to eliminate the apramycin resistance, the competent state of the NZN111 strain which has been knocked out by the phosphoenolpyruvate carboxylase (PPC) gene, and the positive transformation obtained The child is Escherichia coli BA204.

实施例 2  Example 2

本实施例说明构建共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸酶的表达质粒, 恢复重组 菌株在厌氧条件下代谢木糖的能力, 得到菌株 Escherichia coli BA205。  This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malic enzyme to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA205 was obtained.

1、 以缺乏乳酸脱氢酶基因 UdhA , 丙酮酸甲酸裂解酶基因 pjm活性的 . / ΝΖΝ111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株 (同实施例 1 )。 1. In the absence of lactate dehydrogenase gene UdhA, pyruvate formate lyase gene pjm activity. / ΝΖΝ111 The strain was a starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out to obtain a competent strain lacking WM, pflB and PPC (the same as in Example 1).

2、 构建共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸酶的表达质粒, 其过程包括: 2. Constructing an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malic enzyme, the process comprising:

( 1 )合成上下游都带有 HindUl酶切位点的引物, (1) synthesizing primers with HindUl cleavage sites upstream and downstream,

上游引物: 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';  Upstream primer: 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';

下游引物: 5'- CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'。  Downstream primer: 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.

(2) 以 Ba ZZM MMfo基因组 DNA为模板, PCR扩增目的基因片段, 反应条件为: 94°C, 5 min; (94 °C 45 s, 55 °C 45 s, 72°C 100 s, 35个循环); 72 °C , 10 min。 纯化扩增出的 基因 和表达质粒 pTrc99a- 分别用 H dlll单酶切、连接获得重组质粒 pTrc99a-^cA-pd。重组质粒 pTrc99a- / -p 的单双酶切鉴定图如图 9所示。 (2) The target gene fragment was amplified by PCR using Ba ZZM MMfo genomic DNA as template. The reaction conditions were: 94 ° C, 5 min ; (94 ° C 45 s, 55 ° C 45 s, 72 ° C 100 s, 35 Cycles); 72 °C, 10 min. The purified amplified gene and the expression plasmid pTrc99a- were digested with H dlll and ligated, respectively, to obtain a recombinant plasmid pTrc99a-^cA-pd. A single-double digestion map of the recombinant plasmid pTrc99a- / -p is shown in Figure 9.

3、 将质粒 pTrC99a- /b -pC t导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化 酶 (PPC)基因的 NZN 111菌株的感受态, 获得的阳性转化子即为 Escherichia coll BA205。 3. The plasmid pTr C 99a- /b -p C t was introduced before the apramycin resistance was eliminated, and the competent state of the NZN 111 strain of the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. The positive transformant is Escherichia coll BA205.

实施例 3  Example 3

本实施例说明构建共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸脱氢酶的表达质粒, 恢复 重组菌株在厌氧条件下代谢木糖的能力, 得到菌株 Escherichia coli BA206。  This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malate dehydrogenase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA206 was obtained.

1、 以缺乏乳酸脱氢酶基因 UdhA , 丙酮酸甲酸裂解酶基因 pflB~)活性的 .co/ NZNl l l 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 MM、 pflB 和 PPC的感受态菌株 (同实施例 1 )。  1. The .co/ NZNl ll strain lacking lactate dehydrogenase gene UdhA and pyruvate formate lyase gene pflB~) was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. At the same time, the competent strains of MM, pflB and PPC were lacking (same as in Example 1).

2、 构建共表达磷酸烯醇式丙酮酸羧化激酶和苹果酸脱氢酶的表达质粒, 其过程包括: 2. Constructing an expression plasmid co-expressing phosphoenolpyruvate carboxylase and malate dehydrogenase, the process comprising:

( 1 )合成上下游都带有 H U1酶切位点的引物, (1) synthesizing primers with H U1 cleavage sites upstream and downstream,

上游引物: 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';  Upstream primer: 5'- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';

下游引物: 5'- CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'。  Downstream primer: 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.

(2) 以 Bod/to raMfc基因组 DNA为模板, PCR扩增目的基因片段, 反应条件为: 94°C, 5 min; (94 °C 45 s, 55 °C 45 s, 72°C 100 s, 35个循环); 72 °C , 10 min。 纯化扩增出的;? 基因 和表达质粒 pTrc99a-™ft分别用 H'«i/III单酶切、连接获得重组质粒 pTrc99a-w¾^-pd。重组质粒 pTrc99a-mi*-pd的单双酶切鉴定图如图 10所示。 (2) Using Bod/to raMfc genomic DNA as a template, PCR amplification of the target gene fragment was carried out at 94 ° C for 5 min ; (94 ° C for 45 s, 55 ° C for 45 s, 72 ° C for 100 s, 35 cycles); 72 °C, 10 min. The purified and amplified plasmid pTrc99a-TMft was digested with H'«i/III and ligated, respectively, to obtain the recombinant plasmid pTrc99a-w3⁄4^-pd. A single double digestion map of the recombinant plasmid pTrc99a-mi*-pd is shown in FIG.

3、 将质粒 pTrC99a- ift-p 导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化 酶 (PPC)基因的 NZN 111菌株的感受态, 获得的阳性转化子即为 Escherichia coli BA206。 3. The competent strain of NZN 111 strain which has been knocked out of the phosphoenolpyruvate carboxylase (PPC) gene before the plasmid pT rC 99 a - ift-p was introduced, and the positive transformation was obtained. The child is Escherichia coli BA206.

实施例 4  Example 4

本实施例说明构建共表达磷酸烯醇式丙酮酸羧化激酶和丙酮酸羧化酶的表达质粒, 恢复 重组菌株在厌氧条件下代谢木糖的能力, 得到菌株 Escherichia coli BA207。  This example illustrates the construction of an expression plasmid co-expressing phosphoenolpyruvate carboxylase and pyruvate carboxylase to restore the ability of the recombinant strain to metabolize xylose under anaerobic conditions, and the strain Escherichia coli BA207 was obtained.

1、 以缺乏乳酸脱氢酶基因(WM), 丙酮酸甲酸裂解酶基因 pflB 活性的 .«^· ΝΖΝ111 菌株为出发菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶(PPC )基因, 得到同时缺乏 WM、 pflB 和 PPC的感受态菌株 (同实施例 1 )。  1. The strain lacking lactate dehydrogenase gene (WM) and pyruvate formate lyase gene pflB was used as the starting strain, and the phosphoenolpyruvate carboxylase (PPC) gene was knocked out. At the same time, the competent strains of WM, pflB and PPC were lacking (same as in Example 1).

2、 构建共表达磷酸烯醇式丙酮酸羧化激酶和丙酮酸羧化酶的表达质粒, 其过程包括: 2. Constructing an expression plasmid co-expressing phosphoenolpyruvate carboxylase and pyruvate carboxylase, the process comprising:

( 1 )合成上下游都带有 H m酶切位点的引物, (1) synthesizing primers with H m cleavage sites upstream and downstream,

上游引物: 5,- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';  Upstream primer: 5,- CCCAAGCTTATGAACTCAGTTGATTTGACCG -3 ';

下游引物: 5'- CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'。  Downstream primer: 5'-CCCAAGCTTGCATTCCGTCAATTAAAACAAG-3'.

(2) 以 BadZto ^ Mfo基因组 DNA为模板, PCR扩增目的基因片段, 反应条件为: 94°C, 5 min; (94 °C 45 s , 55 °C 45 s, 72°C 100 s, 35个循环); 72 °C , 10 min。 纯化扩增出的 pd基因 和表达质粒 pTrc99a-/?yc分别用 H^ffll单酶切、 连接获得重组质粒 pTrc99a-ro (^d。 重组质粒 pTrc99a-/^c-/7 的单双酶切鉴定图如图 11所示。 (2) PCR amplification of the target gene fragment using BadZto ^ Mfo genomic DNA as a template, the reaction conditions are: 94 ° C, 5 min ; (94 °C 45 s, 55 °C 45 s, 72 °C 100 s, 35 cycles); 72 °C, 10 min. The purified pd gene and the expression plasmid pTrc99a-/?yc were digested with H^ffll and ligated, respectively, to obtain the recombinant plasmid pTrc99a-ro (^d. Recombinant plasmid pTrc99a-/^c-/7 The identification map is shown in Figure 11.

3、 将质粒 pTrc ^-ro -prtt导入之前消除安普霉素抗性, 已敲除磷酸烯醇式丙酮酸羧化 酶 (PPC)基因的 NZN 111菌株的感受态, 获得的阳性转化子即为 Escherichia coll BA207。  3. Except for the apramycin resistance before introduction of the plasmid pTrc ^-ro -prtt, the competent state of the NZN 111 strain having the phosphoenolpyruvate carboxylase (PPC) gene knocked out, and the obtained positive transformant is For Escherichia coll BA207.

实施例 5  Example 5

本实施例说明实施例 1的新构建的重组大肠杆菌 BA204与出发菌株大肠杆菌 NZNl l l发酵 产酸能力的对比。  This example illustrates the comparison of the acidogenic ability of the newly constructed recombinant Escherichia coli BA204 of Example 1 with the starting strain Escherichia coli NZNl l1.

大肠杆菌 en'C/u'fl BA204能够高效利用木糖发酵, 并大量积累丁二酸, 采用两阶 段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌体 OD6(K) 至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6Q。=3左右时,按接种量 10%转接至血清瓶中厌 氧发酵, 发酵 48 h。 E. coli e n' C /u' fl BA204 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and access from the cryopreservation tube. In the flask, when the aerobic cultured cells OD 6 (K) to 0.4 to 0.6 were induced with 0.3 mM IPTG to OD 6Q . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+木糖 (20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青霉素 50 g/mL)十 0.3 mM IPTG。  The anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.

发酵结果见表 1。  The fermentation results are shown in Table 1.

表 1 Escherichia coli BA204与出发菌株发酵产酸的结果比较  Table 1 Comparison of the results of fermentation of acid produced by Escherichia coli BA204 and starting strains

Figure imgf000009_0001
Figure imgf000009_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 6  Example 6

本实施例说明新构建的重组大肠杆菌 BA204与出发菌株大肠杆菌 NZNl l l发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZNl l1.

大肠杆菌 Escherichia coli BA204能够高效利用玉米芯水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (νΛ接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6(K)=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA204 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vΛ inoculum from the cryotube to the flask, when aerobic The cultured OD 6 was induced to 0.3 mM IPTG to about OD 6 (K) = 3 to about 0.4 to 0.6, and then transferred to a serum bottle for anaerobic fermentation at a dose of 10%, and fermented for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+玉米芯水解液 (总糖 20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 2。  The fermentation results are shown in Table 2.

表 2 Escherichia coli BA204与出发菌株发酵产酸的结果比较  Table 2 Comparison of the results of fermentation of Escherichia coli BA204 with starting strains

Figure imgf000009_0002
0 7.02 16 ND ND ND ND ND ND
Figure imgf000009_0002
0 7.02 16 ND ND ND ND ND ND

BA204 BA204

48 6.55 0 ND 14.4 0.5 ND 0.5 ND 注: ND表示未检测到。  48 6.55 0 ND 14.4 0.5 ND 0.5 ND Note: ND means not detected.

实施例 7  Example 7

本实施例说明新构建的重组大肠杆菌 BA204与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA204能够高效利用稻草秸秆水解液发酵,并大量积累丁二酸, 釆用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6Q。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6Q。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA204 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid. The two-stage fermentation method is characterized by 1% (v/v) inoculum from the cryotube into the flask. When aerobic cultured cells OD 6Q . It was induced to OD 6Q with 0.3 mM IPTG to about 0.4 to 0.6 . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+稻草秸秆水解液 (总糖 20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青 霉素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) + 0.3 mM IPTG.

发酵结果见表 3。  The fermentation results are shown in Table 3.

表 3 Escherichia coli BA204与出发菌株发酵产酸的结果比较  Table 3 Comparison of the results of fermentation of Escherichia coli BA204 with starting strains

Figure imgf000010_0001
Figure imgf000010_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 8  Example 8

本实施例说明新构建的重组大肠杆菌 BA204与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA204 with the fermentation ability of the starting strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA204能够高效利用甘蔗渣水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (vA接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA204 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+甘蔗渣水解液 (总糖 20 g/L 碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 4.  The fermentation results are shown in Table 4.

表 4 Escherichia coli BA204与出发菌株发酵产酸的结果比较  Table 4 Comparison of the results of fermentation of Escherichia coli BA204 with starting strains

Figure imgf000010_0002
注: ND表示未检测到,
Figure imgf000010_0002
Note: ND means not detected,

实施例 9  Example 9

本实施例说明新构建的重组大肠杆菌 BA205与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 cAen'C/u i CO« BA205能够高效利用木糖发酵, 并大量积累丁二酸, 采用两阶 段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌体 OD6(K) 至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6QQ=3左右时,按接种量 10%转接至血清瓶中厌 氧发酵, 发酵 48 h。 E. coli cA e n' C /ui CO « BA205 is able to efficiently utilize xylose fermentation and accumulate a large amount of succinic acid. It is a two-stage fermentation method characterized by a 1% (v/v) inoculum from the frozen storage tube. In a triangular flask, when the aerobic cultured OD 6 (K) is about 0.4 to 0.6 and induced with 0.3 mM IPTG to OD 6QQ = 3, the anaerobic fermentation is transferred to the serum bottle by 10% of the inoculum. Fermentation for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+木糖 (20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青霉素 50 g/mL)十 0.3 mM IPTG。  The anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.

发酵结果见表 5。  The fermentation results are shown in Table 5.

Figure imgf000011_0001
Figure imgf000011_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 10  Example 10

本实施例说明新构建的重组大肠杆菌 BA205与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA205能够高效利用玉米芯水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6(K)=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA205 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and is inserted into the flask from the cryotube. When aerobic cultured cells OD 6 . . When induced by 0.3 mM IPTG to about OD 6 (K) = 3 to about 0.4 to 0.6, 10% of the inoculum was transferred to a serum bottle for anaerobic fermentation, and fermentation was carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+玉米芯水解液 (总糖 20 g/L 碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 6。  The fermentation results are shown in Table 6.

表 6 Escherichia coli BA205与出发菌株发酵产酸的结果比较  Table 6 Comparison of the results of fermentation of Escherichia coli BA205 with starting strains

Figure imgf000011_0002
Figure imgf000011_0002

注: ND表示未检测到 E Note: ND means no E is detected.

实施例 11 本实施例说明新构建的重组大肠杆菌 BA205与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。 Example 11 This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA205能够高效利用稻草秸秆水解液发酵,并大量积累丁二酸, 釆用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6Q至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6Q=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA205 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid. The two-stage fermentation method is characterized by 1% (v/v) inoculum from the frozen tube into the flask. When aerobic cultured cells OD 6 . Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG. When Q = 3 or so, transfer to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and ferment for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+稻草秸秆水解液 (总糖 20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青 霉素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) + 0.3 mM IPTG.

发酵结果见表 7。  The fermentation results are shown in Table 7.

表 7 Escherichia coli BA205与出发菌株发酵产酸的结果比较  Table 7 Comparison of the results of fermentation of Escherichia coli BA205 with starting strains

Figure imgf000012_0001
Figure imgf000012_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 12  Example 12

本实施例说明新构建的重组大肠杆菌 BA205与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA205 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA205能够高效利用甘蔗渣水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (vA接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA205 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum from the cryotube into the flask, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+甘蔗渣水解液 (总糖 20 g/L 碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 8。  The fermentation results are shown in Table 8.

表 8 Escherichia coli BA205与出发菌株发酵产酸的结果比较  Table 8 Comparison of the results of fermentation of Escherichia coli BA205 with starting strains

Figure imgf000012_0002
Figure imgf000012_0002

注: ND表示未检测到。  Note: ND means not detected.

实施例 13  Example 13

本实施例说明新构建的重组大肠杆菌 BA206与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。 大肠杆菌 c/ien'c/ 'ii CO/ BA206能够高效利用木糖发酵, 并大量积累丁二酸, 采用两阶 段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌体 OD6(K) 至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6M=3左右时,按接种量 10%转接至血清瓶中厌 氧发酵, 发酵 48 h。 This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the original strain Escherichia coli NZN1 11. Escherichia coli c/i e n'c/ 'ii CO / BA206 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid, using a two-stage fermentation method, which is characterized by a 1% (v/v) inoculum from the frozen The storage tube is connected to the triangular flask. When the aerobic cultured bacterium OD 6 (K) is about 0.4~0.6 and induced with 0.3 mM IPTG to OD 6M = 3, the inoculum is 10% transferred to the serum bottle. Oxygen fermentation, fermentation for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+木糖 (20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青霉素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB + xylose (20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 9。  The fermentation results are shown in Table 9.

表 9 Escherichia coli BA206与出发菌株发酵产酸的结果比较  Table 9 Comparison of the results of fermentation of Escherichia coli BA206 with starting strains

Figure imgf000013_0001
Figure imgf000013_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 14  Example 14

本实施例说明新构建的重组大肠杆菌 BA206与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA206能够高效利用玉米芯水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA206 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and is inserted into the flask from the cryotube. When aerobic cultured cells OD 6 . . It was induced to OD 6 with 0.3 mM IPTG to about 0.4 to 0.6. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+玉米芯水解液 (总糖 20 g/L) +碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)十 0.3 mM IPTG。  The anaerobic phase medium was: LB + corn cob hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) ten 0.3 mM IPTG.

发酵结果见表 10。  The fermentation results are shown in Table 10.

Figure imgf000013_0002
Figure imgf000013_0002

注: ND表示未检测到。  Note: ND means not detected.

实施例 15  Example 15

本实施例说明新构建的重组大肠杆菌 BA206与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA206能够高效利用稻草秸秆水解液发酵,并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6Q至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA206 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum from the cryotube into the flask. Aerobic culture Body OD 6 . Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+稻草秸秆水解液 (总糖 20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青 霉素 50 g/mL)十 0.3 mM IPTG。  The anaerobic phase medium was: LB + straw straw hydrolysate (total sugar 20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g / mL) ten 0.3 mM IPTG.

发酵结果见表 11。 The fermentation results are shown in Table 11.

Figure imgf000014_0001
Figure imgf000014_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 16  Example 16

本实施例说明新构建的重组大肠杆菌 BA206与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA206 with the fermentation ability of the starting strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA206能够高效利用甘蔗渣水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (vA接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA206 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+甘蔗渣水解液 (总糖 20 g/L 碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 12。 The fermentation results are shown in Table 12.

Figure imgf000014_0002
Figure imgf000014_0002

注: ND表示未检测到。  Note: ND means not detected.

实施例 17  Example 17

本实施例说明新构建的重组大肠杆菌 BA207与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 en'C/u'fl BA207能够高效利用木糖发酵, 并大量积累丁二酸, 采用两阶 段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌体 OD6Q() 至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6Q。=3左右时,按接种量 10%转接至血清瓶中厌 氧发酵, 发酵 48 h。 有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。 E. coli e n' C /u' fl BA207 can efficiently utilize xylose fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and access from the cryotube. In the flask, when the aerobic cultured cells OD 6Q () to 0.4 to 0.6 were induced with 0.3 mM IPTG to OD 6Q . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours. The aerobic phase medium was: LB + Amp (ampicillin 50 g/mL).

厌氧阶段培养基为: LB+木糖 (20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青: 素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB + xylose (20 g / L) + basic magnesium carbonate 0.48 g + Amp (ampicillin: 50 g / mL) + 0.3 mM IPTG.

发酵结果见表 13。  The fermentation results are shown in Table 13.

表 13 Escherichia coli BA207与出发菌株发酵产酸的结果比较  Table 13 Comparison of the results of fermentation of Escherichia coli BA207 with starting strains

Figure imgf000015_0001
Figure imgf000015_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 18  Example 18

本实施例说明新构建的重组大肠杆菌 BA207与出发菌株大肠杆菌 NZN1 11发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the original strain Escherichia coli NZN1 11.

大肠杆菌 Escherichia coli BA207能够高效利用玉米芯水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (v/v)接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6Q至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA207 can efficiently utilize corncob hydrolysate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (v/v) inoculum and is inserted into the flask from the cryotube. When aerobic cultured cells OD 6 . Q to 0.4 to 0.6 was induced to OD 6 with 0.3 mM IPTG. . When it is around 3, it is transferred to the serum bottle for anaerobic fermentation according to the inoculation amount of 10%, and fermentation is carried out for 48 hours.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+玉米芯水解液 (总糖 20 g/L)十碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic phase medium was: LB+ corncob hydrolysate (total sugar 20 g/L) decahydrate magnesium carbonate 0.48 g+Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 14。  The fermentation results are shown in Table 14.

Figure imgf000015_0002
Figure imgf000015_0002

注: ND表示未检测到。  Note: ND means not detected.

实施例 19  Example 19

本实施例说明新构建的重组大肠杆菌 BA207与出发菌株大肠杆菌 NZNl l l发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the starting strain Escherichia coli NZNl l l.

大肠杆菌 Escherichia coli BA207能够高效利用稻草秸秆水解液发酵,并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (vA接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6Q=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA207 can efficiently ferment the straw straw hydrolysate and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum from the cryotube to the flask, when aerobic The cultured OD 6 was induced to 0.3% with IPTG of 0.3 mM to about OD 6 . When Q = 3, 10% of the inoculum was transferred to a serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+稻草秸秆水解液 (总糖 20 g/L)+碱式碳酸镁 0.48 g+Amp (氨苄青 霉素 50 g/mL)+0.3 mM IPTGc The anaerobic stage medium is: LB+ straw straw hydrolysate (total sugar 20 g/L) + basic magnesium carbonate 0.48 g+Amp (ammonium chloride) Mycin 50 g/mL) +0.3 mM IPTGc

发酵结果见表 15。 The fermentation results are shown in Table 15.

Figure imgf000016_0001
Figure imgf000016_0001

注: ND表示未检测到。  Note: ND means not detected.

实施例 20  Example 20

本实施例说明新构建的重组大肠杆菌 BA207与出发菌株大肠杆菌 NZNl l l发酵产酸能力 的对比。  This example illustrates the comparison of the newly constructed recombinant Escherichia coli BA207 with the fermentation ability of the starting strain Escherichia coli NZNl l l.

大肠杆菌 Escherichia coli BA207能够高效利用甘蔗渣水解液发酵, 并大量积累丁二酸, 采用两阶段发酵方式, 其特征在于按 1% (vA接种量从冻存管接入三角瓶中, 当有氧培养菌 体 OD6。。至 0.4〜0.6左右用 0.3 mM的 IPTG诱导至 OD6。。=3左右时,按接种量 10%转接至血 清瓶中厌氧发酵, 发酵 48 h。 Escherichia coli BA207 can efficiently utilize the sugarcane residue hydrolyzate fermentation and accumulate a large amount of succinic acid. It adopts a two-stage fermentation method, which is characterized by 1% (vA inoculum is introduced into the flask from the cryotube, when aerobic The cultured OD 6 was induced to 0.3 mM to 0.3 mM IPTG to OD 6 . When the concentration was about 3, 10% of the inoculum was transferred to the serum bottle for anaerobic fermentation, and fermentation was carried out for 48 h.

有氧阶段培养基为: LB+ Amp (氨苄青霉素 50 g/mL)。  The aerobic phase medium is: LB + Amp (ampicillin 50 g / mL).

厌氧阶段培养基为: LB+甘蔗渣水解液 (总糖 20 g/L 碱式碳酸镁 0.48 g+Amp (氨苄青霉 素 50 g/mL)+0.3 mM IPTG。  The anaerobic stage medium was: LB + bagasse hydrolysate (total sugar 20 g/L basic magnesium carbonate 0.48 g + Amp (ampicillin 50 g/mL) + 0.3 mM IPTG.

发酵结果见表 16。 The fermentation results are shown in Table 16.

Figure imgf000016_0002
Figure imgf000016_0002

注: ND表示未检测到 ε Note: ND means no ε detected

Claims

权利要求 Rights request 1. 一种利用木糖代谢产丁二酸大肠杆菌基因工程菌的构建方法,其特征在于包括如 下步骤: 1. A method for constructing a genetically engineered Escherichia coli bacteria that utilizes xylose metabolism to produce succinic acid, which is characterized by comprising the following steps: ( 1 ) 以缺乏乳酸脱氢酶基因, 丙酮酸甲酸裂解酶基因活性的大肠杆菌菌株为出发 菌株, 敲除其中磷酸烯醇式丙酮酸羧化酶基因, 得到同时缺乏 ldhA、 pflB和 PPC的感 受态菌株; (1) Taking an Escherichia coli strain lacking lactate dehydrogenase gene and pyruvate formate lyase gene activity as the starting strain, knocking out the phosphoenolpyruvate carboxylase gene, and obtaining the feeling of lacking ldhA, pflB and PPC at the same time State strains; ( 2 ) 单独纯化扩增出磷酸烯醇式丙酮酸羧化激酶基因, 或者纯化扩增出磷酸烯醇 式丙酮酸羧化激酶基因, 以及选择自苹果酸酶基因、 苹果酸脱氢酶基因或丙酮酸羧化酶 基因这三种基因中的一种, 构建得到单独过量表达磷酸烯醇式丙酮酸羧化激酶, 或者过 量表达磷酸烯醇式丙酮酸羧化激酶, 以及选择自苹果酸酶、 苹果酸脱氢酶或丙酮酸羧化 酶这三种酶中的一种的表达质粒; (2) Separately purify and amplify the phosphoenolpyruvate carboxykinase gene, or purify and amplify the phosphoenolpyruvate carboxykinase gene, and select from the malic enzyme gene, malate dehydrogenase gene or One of the three genes, pyruvate carboxylase gene, was constructed to overexpress phosphoenolpyruvate carboxykinase alone, or to overexpress phosphoenolpyruvate carboxykinase, and to select from malic enzyme, An expression plasmid for one of the three enzymes, malate dehydrogenase or pyruvate carboxylase; ( 3 )将步骤 (2 )所述的质粒导入步骤 (1 )得到的感受态菌株, 获得阳性转化子; (3) Introduce the plasmid described in step (2) into the competent strain obtained in step (1) to obtain positive transformants; ( 4 )利用步骤 (3 ) 的阳性转化子单独过量表达磷酸烯醇式丙酮酸羧化激酶, 或者 过量表达磷酸烯醇式丙酮酸羧化激酶, 以及选择自苹果酸酶、 苹果酸脱氢酶或丙酮酸羧 化酶这三种酶中的一种, 恢复其在厌氧条件下代谢木糖的能力, 得到可利用木糖代谢产 丁二酸基因工程菌。 (4) Utilize the positive transformant of step (3) to overexpress phosphoenolpyruvate carboxykinase alone, or to overexpress phosphoenolpyruvate carboxykinase, as well as malic enzyme and malate dehydrogenase. Or one of the three enzymes, pyruvate carboxylase, to restore its ability to metabolize xylose under anaerobic conditions, and obtain genetically engineered bacteria that can utilize xylose to metabolize succinic acid.
PCT/CN2012/078817 2011-07-18 2012-07-18 Construction method of escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism Ceased WO2013010483A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110200742.5 2011-07-18
CN2011102007425A CN102296082A (en) 2011-07-18 2011-07-18 Construction method of escherichia coli genetic engineering bacteria for producing succinic acid by utilizing xylose metabolism

Publications (1)

Publication Number Publication Date
WO2013010483A1 true WO2013010483A1 (en) 2013-01-24

Family

ID=45356757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/078817 Ceased WO2013010483A1 (en) 2011-07-18 2012-07-18 Construction method of escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism

Country Status (2)

Country Link
CN (2) CN102296082A (en)
WO (1) WO2013010483A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105779513A (en) * 2016-05-10 2016-07-20 华东理工大学 Method for producing succinic acid by recombinant escherichia coli through fermentation by using glycerol as carbon source

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102399738B (en) * 2011-07-18 2013-12-04 南京工业大学 Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium
CN102296082A (en) * 2011-07-18 2011-12-28 南京工业大学 Construction method of escherichia coli genetic engineering bacteria for producing succinic acid by utilizing xylose metabolism
CN103131663B (en) * 2013-03-07 2014-08-06 中国科学院天津工业生物技术研究所 Recombinant bacteria for increasing yield of succinic acid and construction method thereof
CN103320366B (en) * 2013-07-10 2014-12-31 南京工业大学 Screening and application of high-yield succinic acid escherichia coli by anaerobic utilization of synthetic culture medium
CN106167772B (en) * 2016-06-21 2019-05-17 中国科学院过程工程研究所 The Recombinant organism and its construction method of a kind of high yield pyruvic acid and application
CN106544285B (en) * 2016-12-07 2019-07-02 江南大学 A kind of method for strengthening the synthesis of pyruvate by T. glabrata
CN110951660B (en) * 2019-12-19 2021-12-03 江南大学 Construction and application of Escherichia coli engineering bacterium for producing malic acid by fixing CO2
CN116265583A (en) * 2021-12-16 2023-06-20 山东理工大学 Recombinant bacteria for synthesizing succinic acid by using xylose to fix carbon dioxide and its construction method
CN114958703B (en) * 2022-06-15 2024-01-05 山东理工大学 Recombinant bacterium for synthesizing succinic acid by utilizing grease, construction method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102296082A (en) * 2011-07-18 2011-12-28 南京工业大学 Construction method of escherichia coli genetic engineering bacteria for producing succinic acid by utilizing xylose metabolism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101255405B (en) * 2008-04-11 2011-06-08 南京工业大学 Novel constructed high-yield malic acid gene engineering bacterium and method for producing malic acid by using same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102296082A (en) * 2011-07-18 2011-12-28 南京工业大学 Construction method of escherichia coli genetic engineering bacteria for producing succinic acid by utilizing xylose metabolism

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HUI WU ET AL.: "Improved succinic acid production in the anaerobic culture of an Escherichia coli pflB ldhA double mutant as a result of enhanced Anaplerotic activities in the preceding aerobic culture", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 73, no. 24, 31 December 2007 (2007-12-31), pages 7837 - 7843 *
LIANG LIYA ET AL.: "Effect of overexpression of malate dehydrogenase on succinic acid Production in Escherichia coli NZN111", CHINESE JOURNAL OF BIOTECHNOLOGY, vol. 27, no. 7, 25 January 2011 (2011-01-25), pages 1005 - 1012 *
MA JIANGFENG ET AL.: "Effects of fermentation regulation and molecular modification on succinate production by E. coli based key enzyme expression", JOURNAL OF NANJING UNIVERSITY TECHNOLOGY (NATURAL SCIENCE EDITION), vol. 33, no. 3, 31 May 2011 (2011-05-31), pages 58 - 61 *
YU LI ET AL.: "Effect of overexpression of Bacillus subtilis phosphoenolpyruvate Carboxykinase on succinate production in Escherichia coli", MICROBIOLOGY CHINA, vol. 37, no. 3, 20 March 2010 (2010-03-20), pages 325 - 330 *
YU LI ET AL.: "Fermentation characteristics research of recombinant Escherichia coli for succinate production", CHINA BIOTECHNOLOGY, vol. 30, no. 9, 31 December 2010 (2010-12-31), pages 43 - 48 *
ZHAN XIAOBEI ET AL.: "Recent development in metabolic engineering for production of succinic acid by Escherichia coli", THE CHINESE JOURNAL OF PROCESS ENGINEERING, vol. 7, no. 4, 31 August 2007 (2007-08-31), pages 840 - 846 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105779513A (en) * 2016-05-10 2016-07-20 华东理工大学 Method for producing succinic acid by recombinant escherichia coli through fermentation by using glycerol as carbon source
CN105779513B (en) * 2016-05-10 2019-12-06 华东理工大学 Method for producing succinic acid by fermentation of recombinant escherichia coli by using glycerol as carbon source

Also Published As

Publication number Publication date
CN102296082A (en) 2011-12-28
CN102618477A (en) 2012-08-01

Similar Documents

Publication Publication Date Title
WO2013010483A1 (en) Construction method of escherichia coli genetically engineered bacteria producing succinic acid by xylose metabolism
CN101255405B (en) Novel constructed high-yield malic acid gene engineering bacterium and method for producing malic acid by using same
CN102618570B (en) Method for constructing escherichia coli genetic engineering bacteria for producing fumaric acid
CN104593308B (en) A kind of genetic engineering bacterium and its construction method and the application in production xylitol
CN115074376B (en) Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation
WO2013086907A1 (en) Genetic engineering strain for producing succinic acid by using glucose and method for producing acid by fermenting the strain
CN117004547B (en) A genetically engineered bacterium that de novo synthesizes cis, cis-muconic acid using glucose as a substrate and its application
Tenhaef et al. Production of D-xylonic acid using a non-recombinant Corynebacterium glutamicum strain
CN102102086A (en) L-lactate dehydrogenase gene-deleted engineering bacterium and construction method and application thereof
CN105543214A (en) Construction method and applications of metabolic engineering escherichia coli strain for producing succinic acid by using acetic acid
CN102154339A (en) Construction method of gene engineering strain for producing succinic acid escherichia coli
Khunnonkwao et al. Re-engineering Escherichia coli KJ122 to enhance the utilization of xylose and xylose/glucose mixture for efficient succinate production in mineral salt medium
CN107338258A (en) The method for producing the engineering bacteria structure and its production beta Alanine of beta Alanine
CN102399738B (en) Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium
CN102643774B (en) Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium
CN102864116B (en) Gene engineering bacterium for producing succinic acid and construction and application thereof
CN102604880A (en) Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium
CN102643775A (en) Gene engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of gene engineering bacterium
CN101993850B (en) Genetic engineering bacteria for producing D-lactic acid and constructon method and application thereof
CN113564090B (en) A method for constructing recombinant ectoine-producing bacteria and its application
CN103937733B (en) Genetic engineering strain for producing succinic acid by using sucrose and method for producing succinic acid by fermentation of strain
CN117304283A (en) An mreC mutant and its application in L-valine fermentation production
CN104293817B (en) Construction methods and uses of recombinant plasmid for producing succinic acid, and genetic engineering bacterium
CN102649970B (en) Method for producing succinic acid by using Escherichia coli BA305 through fermentation
CN104232553A (en) Engineering strain for producing succinic acid at low pH value and method for producing succinic acid by fermentation of engineering strain

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12814456

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12814456

Country of ref document: EP

Kind code of ref document: A1